An unusual presentation of inflammatory myopathy in a patient on natalizumab treatment for multiple sclerosis: A case report and review of myopathological classification of inflammatory myopathy
Journal Title: International Journal of Clinical Rheumatology - Year 2018, Vol 13, Issue 3
Abstract
Acquired immune and inflammatory myopathies (IIMs) are traditionally subdivided into dermatomyositis, polymyositis, inclusion body myositis (IBM) and necrotizing autoimmune myopathy (NAM). Our patient is a 38-year old female who had history of Multiple Sclerosis and was on Natalizumab. Almost a year later, she presented with acute proximal bilateral upper extremity weakness with elevated CPK. She was initially labeled as having ‘viral myositis’. Her subsequent two admissions demonstrated worsening of muscle weakness with dysphagia which was initially unresponsive to high dose of steroids. She had an EMG which showed irritative myopathy and a muscle biopsy which showed IMPP. She eventually responded to pulse dose of steroids and IVIG and Natalizumab was held. The temporal relationship between the development of inflammatory myopathy in our patient and subsequent improvement in her course after discontinuation of the drug suggests that natalizumab may have played a role in our patient’s disease and warrants further investigation and vigilance. In addition to the case report, we hope to elaborate on the myopathological descriptions increasingly being used to describe the IIMs and to explore the potential link between natalizumab and the onset of IIM in our patient.
Authors and Affiliations
Beenish Zulfiqar, Jacquelin Chua, Stacy Weinberg, Sobia Hassan
Keywords
Related Articles
- EP ID EP604508
- DOI -
- Views 57
- Downloads 0
Awareness on dietary restriction in case of gout
Gout is a rheumatologically oriented metabolic disease usually occurs due to rise in uric acid in the blood by altering dietary intake. We know gout affects about 1% to 2% of the Western population at some point in their...
Psychological status is associated with drug efficacy in patients with ankylosing spondylitis
Background: Quality of life in patients with Ankylosing Spondylitis (AS) is significantly associated with psychological disorders, such as depression and anxiety. Effective prevention and control of depression and anxiet...
T helper 17 cells and interleukin-17 in patients with rheumatoid arthritis
Rheumatoid Arthritis (RA) is one of the most prevalent autoimmune disease which may lead to a shorter life expectancy and lessened personal satisfaction. it is driven by effector T cells, particularly Th17 cells which po...
Case finding for the primary prevention of fragility fractures with FRAX (without BMD) in those over 70 years: Reducing the reliance on BMD as the primary tool
Objective(s): To develop and evaluate age-stratified fracture risk score thresholds without dual X-ray absorptiometry (DXA) to manage osteoporosis. Methods: A multi-centered cohort study of persons over 70 years recruit...
Estimation of bone fracture risk using FRAX model in some regions of Russian Federation
Purpose: To estimate the absolute risk (AR) of fractures in urban population of some Russian regions using Russia-specific FRAX® model, as well as to evaluate therapeutic intervention threshold (TIT) adopted in Russia....